Wednesday, January 21, 2009

APP Pharmaceuticals Launches Rocuronium Bromide Injection

Jan 20, 2009 - APP Pharmaceuticals, Inc., a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has launched Rocuronium Bromide Injection, the generic equivalent of Organon's Zemuron.

The details can be read here.

No comments: